- Home
- ICON vs PRFX Comparison
ICON vs PRFX Comparison
Compare ICON & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICON
- PRFX
- Stock Information
- Founded
- ICON 2023
- PRFX 2007
- Country
- ICON Greece
- PRFX Israel
- Employees
- ICON N/A
- PRFX N/A
- Industry
- ICON
- PRFX Biotechnology: Pharmaceutical Preparations
- Sector
- ICON
- PRFX Health Care
- Exchange
- ICON Nasdaq
- PRFX Nasdaq
- Market Cap
- ICON 3.6M
- PRFX 3.6M
- IPO Year
- ICON 2024
- PRFX 2020
- Fundamental
- Price
- ICON $1.68
- PRFX $2.06
- Analyst Decision
- ICON Strong Buy
- PRFX Hold
- Analyst Count
- ICON 1
- PRFX 1
- Target Price
- ICON $4.50
- PRFX N/A
- AVG Volume (30 Days)
- ICON 62.0K
- PRFX 55.9K
- Earning Date
- ICON 06-17-2025
- PRFX 06-20-2025
- Dividend Yield
- ICON 206.67%
- PRFX N/A
- EPS Growth
- ICON N/A
- PRFX N/A
- EPS
- ICON N/A
- PRFX N/A
- Revenue
- ICON $5,309,000.00
- PRFX N/A
- Revenue This Year
- ICON $76.76
- PRFX N/A
- Revenue Next Year
- ICON $30.43
- PRFX N/A
- P/E Ratio
- ICON N/A
- PRFX N/A
- Revenue Growth
- ICON 18.61
- PRFX N/A
- 52 Week Low
- ICON $1.60
- PRFX $1.68
- 52 Week High
- ICON $154.00
- PRFX $18.17
- Technical
- Relative Strength Index (RSI)
- ICON N/A
- PRFX 51.59
- Support Level
- ICON N/A
- PRFX $1.93
- Resistance Level
- ICON N/A
- PRFX $2.11
- Average True Range (ATR)
- ICON 0.00
- PRFX 0.10
- MACD
- ICON 0.00
- PRFX 0.03
- Stochastic Oscillator
- ICON 0.00
- PRFX 80.77
About ICON Icon Energy Corp. Common stock
Icon Energy Corp is a Growth-oriented company that operates as a holding company for the purpose of acquiring, owning, chartering and operating dry bulk vessels through its subsidiaries. The company generates its revenues by chartering the Initial Vessels to regional and international dry bulk operators, commodity traders and end users.
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.